The reason so many PBMs are reluctant to offer radical transparency is in doing so their revenues would be cut in half! How many businesses do you know will voluntarily cut their revenues in half? Instead, non-fiduciary PBMs seek out arbitrage opportunities to foster top-line growth. Want to learn more?
Here is what some participants have said about the webinar:
“Thank you Tyrone. Nice job, good information.” David Stoots, AVP
P.S. Yes, it’s recorded. I know you’re busy…so register now and we’ll send you the link to the session recording as soon as it’s ready.
“Thank you! Awesome presentation.” Mallory Nelson, PharmD
“Thank you Tyrone for this informative meeting.” David Wachtel, VP
“…Great presentation! I had our two partners on the presentation as well. Very informative.” Nolan Waterfall, Agent/Benefits Specialist
A snapshot of what you will learn during this 30-minute webinar:
- Hidden cash flow streams in the PBM Industry
- Basic to intermediate level PBM terminologies
- Examples of drugs that you might be covering that are costing you
- The #1 metric to measure when evaluating PBM proposals
- Strategies to significantly reduce costs and improve member health
Sincerely,
TransparentRx
Tyrone D. Squires, MBA
10845 Griffith Peak Drive, Suite 200
Las Vegas, NV 89135
866-499-1940 Ext. 201
P.S. Yes, it’s recorded. I know you’re busy…so register now and we’ll send you the link to the session recording as soon as it’s ready.
